secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2024-04-30T23:59:59+00:00
Accession:  0000896264-24-000138
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q1 net sales $228M (-8% YoY), EPS $0.86, reaffirms FY2024 guidance
------------------------------------------------------------------------

- Net sales $228M (-8% YoY, -5% constant currency); diluted EPS $0.86 (-9% YoY).
- Reiterates FY2024 net sales outlook $850-920M and EPS $2.40-$3.00.
- Greater China active customers +15% YoY, net sales +3% (+7% constant currency).
- Other key markets declined: North Asia net sales -28% YoY, SE Asia -22%, Americas/Europe -12%.
- Repurchased 194k shares for $9M in Q1; $62M remaining under share repurchase authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626424000138/0000896264-24-000138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626424000138/usna-20240430.htm
  HTML page:      https://secwatch.observer/filing/0000896264-24-000138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer